What is the level of liabilities of Ginkgo Bioworks Holdings this year?
Ginkgo Bioworks Holdings has a debt balance of 568.19 M USD this year.
In 2024, Ginkgo Bioworks Holdings's total liabilities amounted to 568.19 M USD, a -29.24% difference from the 803 M USD total liabilities in the previous year.
Ginkgo Bioworks Holdings's liabilities constitute the company's financial obligations and debts owed to external parties and stakeholders. They are categorized into current liabilities, due within a year, and long-term liabilities, which are due over a longer period. A detailed assessment of these liabilities is crucial for evaluating Ginkgo Bioworks Holdings's financial stability, operational efficiency, and long-term viability.
By comparing Ginkgo Bioworks Holdings's liabilities year-over-year, investors can identify trends, shifts, and anomalies in the company’s financial positioning. A decrease in total liabilities often signals financial strengthening, while an increase might indicate enhanced investments, acquisitions, or potential financial strain.
Ginkgo Bioworks Holdings's total liabilities play a significant role in determining the company's leverage and risk profile. Investors and analysts examine this aspect meticulously to ascertain the firm’s ability to meet its financial obligations, which influences investment attractiveness and credit ratings.
Shifts in Ginkgo Bioworks Holdings’s liability structure indicate changes in its financial management and strategy. A reduction in liabilities reflects efficient financial management or debt payoffs, while an increase may suggest expansion, acquisition activities, or accruing operational expenses, each carrying distinct implications for investors.
Ginkgo Bioworks Holdings has a debt balance of 568.19 M USD this year.
The liabilities of Ginkgo Bioworks Holdings have increased by -29.24% dropped compared to the previous year.
High liabilities can pose a risk for investors of Ginkgo Bioworks Holdings, as they can weaken the company's financial position and impair its ability to meet its obligations.
Low liabilities mean that Ginkgo Bioworks Holdings has a strong financial position and is able to meet its obligations without overburdening its finances.
An increase in liabilities of Ginkgo Bioworks Holdings can lead to the company having more obligations and potentially find it more difficult to meet its financial commitments.
A decrease in the liabilities of Ginkgo Bioworks Holdings can lead to the company having fewer obligations and a stronger financial position, which can make it easier for the company to fulfill its financial commitments.
Some factors that can influence the liabilities of Ginkgo Bioworks Holdings include investments, acquisitions, operating costs, and sales development.
The liabilities of Ginkgo Bioworks Holdings are important for investors as they serve as an indicator of the company's financial stability and provide investors with information on how the company meets its financial obligations.
To change its liabilities, Ginkgo Bioworks Holdings can take measures such as cost savings, increasing revenue, selling assets, raising investments, or forming partnerships. It is important for the company to conduct a thorough review of its financial situation to choose the best strategic actions.
Over the past 12 months, Ginkgo Bioworks Holdings paid a dividend of . This corresponds to a dividend yield of about . For the coming 12 months, Ginkgo Bioworks Holdings is expected to pay a dividend of 0 USD.
The current dividend yield of Ginkgo Bioworks Holdings is .
Ginkgo Bioworks Holdings pays a quarterly dividend. This is distributed in the months of .
Ginkgo Bioworks Holdings paid dividends every year for the past 0 years.
For the upcoming 12 months, dividends amounting to 0 USD are expected. This corresponds to a dividend yield of 0 %.
Ginkgo Bioworks Holdings is assigned to the 'Commodities' sector.
To receive the latest dividend of Ginkgo Bioworks Holdings from 6/11/2024 amounting to 0 USD, you needed to have the stock in your portfolio before the ex-date on 6/11/2024.
The last dividend was paid out on 6/11/2024.
In the year 2023, Ginkgo Bioworks Holdings distributed 0 USD as dividends.
The dividends of Ginkgo Bioworks Holdings are distributed in USD.
Our stock analysis for Ginkgo Bioworks Holdings Revenue stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of Ginkgo Bioworks Holdings Revenue. If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.